logo-loader
viewArcadia Biosciences Inc

Full interview: Arcadia Biosciences records some big wins in the 3rd Quarter

Arcadia Biosciences (NASDAQ: RKDA) CEP Matt Plavan joined Proactive’s Steve Darling to discuss the company’s third-quarter results. Plavan also discussed some of the company highlights during that quarter including the latest on their research facilities.

Plavan also discussed their hemp operation and the expansion they had in three states.

Quick facts: Arcadia Biosciences Inc

Price: 5.04 USD

NASDAQ:RKDA
Market: NASDAQ
Market Cap: $43.58 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Thunderbird Entertainment sets record with 7.9 million...

Thunderbird Entertainment (CVE: TBRD-OTC: THBRF) President Mark Miller joined Steve Darling from Proactive in Toronto to share news the company has set a record with the number of viewers watching their programming to start 2020. Miller telling Proactive how they were able to achieve that...

6 hours, 58 minutes ago

2 min read